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Systematic Review

Clinical Outcomes of Superior Capsular
Reconstruction for Massive, Irreparable Rotator Cuff
Tears: A Systematic Review Comparing Acellular
Dermal Allograft and Autograft Fascia Lata
Tyler J. Smith, D.O., Anirudh K. Gowd, M.D., John Kunkel, D.O., Lisa Kaplin, D.O.,
John B. Hubbard, M.D., Kevin E. Coates, M.D., Benjamin R. Graves, M.D., and
Brian R. Waterman, M.D.

Purpose: To investigate clinical outcomes after superior capsular reconstruction (SCR) for the treatment of massive and/
or irreparable rotator cuff tears treated with either allograft or autograft. Methods: Using the Preferred Reporting Items
for Systematic Reviews and Meta Analyses (PRISMA) guidelines, in April 2020 a systematic review was performed using
PubMed, MEDLINE, EMBASE, and Cochrane databases. Clinical studies were assessed for patient-reported outcomes and
range of motion, comparing dermal allografts to fascia lata autografts, with a minimum follow-up of 12 months.
Results: A total of 16 clinical studies involving 598 patients (606 shoulders) were included for data analysis, with a
weighted mean follow-up of 36.9 months (range 12 to 60). Visual analogue scale (VAS) pain scores decreased from 4.0 to
6.9 mm preoperatively to 0 to 2.5 mm postoperatively. American Shoulder & Elbow Surgeons score increased from 20.3 to
54.5 preoperatively to 73.7 to 97.0 postoperatively. Forward ﬂexion increased from 27.0 to 142.7 preoperatively to
134.5 to 167.0 postoperatively. External rotation increased from 13.2 to 41.0 preoperatively to 30.0 to 59.0
postoperatively. Acromiohumeral distance increased from 3.4 to 7.1 mm preoperatively to 6.0 to 9.7 mm postoperatively.
The total rates of complications, graft failure, and revision surgery were 5.6%, 13.9%, and 6.9%, respectively.
Conclusions: Irrespective of tissue source, SCR serves as a reasonable joint-preserving option for massive, irreparable
rotator cuff tears, with favorable short- to midterm improvements in patient-reported outcomes and range of motion.
Level of Evidence: IV, systematic review of level III and IV studies.

T

he management of massive or irreparable rotator
cuff tears is particularly complex for orthopedic
surgeons. Technical challenges include the presence of
muscle atrophy, fatty inﬁltration, scarring or adhesions,
myotendinous retraction, tendon inelasticity, superior
migration of the humeral head, and ultimately, osteoarthritis.1-5 In addition, retear rates of primary repair for

massive rotator cuff tears have been reported to be as
high as 94% within 36 months.6 Treatment options
vary and include arthroscopic debridement, tendon
transfer, interpositional arthroplasty, subacromial
spacer interposition, reverse shoulder arthroplasty
(RSA), and superior capsular reconstruction (SCR).
RSA has become increasingly popular over the last 2
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decades and accounts for nearly half of all shoulder
arthroplasty performed today.7 However, there are
concerns regarding the complication rate of RSA and
the associated revision burden, particularly in younger
patients.8-10
Historically, rotator cuff surgery has focused on
reestablishing the tendinous attachment to its footprint.
More recently, authors have proposed that the superior
capsule may serve as a more integral structure,
whereby restoration of superior capsular defects may
have a greater impact on subsequent glenohumeral
biomechanics.11 SCR has become increasingly popular
in the United States and Europe for the treatment of
massive or irreparable rotator cuff tears.12 However, the
justiﬁcation for its exponential growth has been questioned, as the literature regarding SCR is limited to
several small case series and biomechanical studies. The
purpose of this study was to investigate clinical outcomes after SCR for the treatment of massive or irreparable rotator cuff tears treated with either allograft or
autograft. The authors hypothesized that postoperative
clinical outcomes would demonstrate pain reduction,
improved shoulder function, and improved range of
motion, and that SCR with fascia lata grafts would
demonstrate outcomes superior to those of dermal
matrix grafts.

Methods
Literature Search
A systematic review was registered with PROSPERO
and performed using Preferred Reporting Items for
Systematic Reviews and Meta-Analyses (PRISMA)
guidelines. A comprehensive literature search was
performed using PubMed, Medline (Ovid), EMBASE
(Elsevier), and Cochrane Library (Wiley) electronic
databases in April 2020. MeSH terms were used to increase sensitivity. Additionally, all references in the
included studies were cross-referenced for inclusion if
any were missed by the initial search. The ﬁnal search
was completed on April 10, 2020, independently, by 2
authors (T.J.S., L.K.).
Study Eligibility
Trials were eligible for inclusion if they met the
following criteria: human or cadaveric subjects with
documented massive or irreparable rotator cuff tears,
superior capsular reconstruction, and patient outcome
after 12 months of follow-up for clinical trials. Studies
involving animals, partial rotator cuff tear, rotator cuff
repair, operative technique articles without reported
outcomes, cadaver studies, biomechanical studies, review articles, comments, letters, editorials, duplicates,
and nonrelevant studies were excluded. Case reports,
abstracts without available full text, and foreign language articles without direct translation were excluded.

Study Selection and Data Abstraction
A full-text review was performed by 2 authors (T.J.S.,
L.K.) to conﬁrm appropriateness for inclusion. Any
disagreement between authors during each step of the
review process was resolved by discussion. If consensus
could not be reached, ﬁnal inclusion was decided by a
third reviewer (B.R.W.). A ﬂow diagram outlining the
selection process can be found in Fig 1.
Clinical studies were assessed for multiple outcomes of
interest, including level of evidence, concomitant procedures, visual analogue scale (VAS), Constant score,
Oxford Shoulder Score (OSS), UCLA shoulder score,
American Shoulder & Elbow Surgeons score (ASES),
Subjective Shoulder Value (SSV), acromial humeral distance (AHD), range of motion (ROM), patient satisfaction,
complications, reoperations, revision surgery, conversion
to reverse shoulder arthroplasty, and graft failure. Graft
failure was deﬁned as retear conﬁrmed by magnetic
resonance imaging (MRI) or ultrasound, partially healed
graft conﬁrmed by MRI or ultrasound at ﬁnal radiologic
follow-up, or loss of graft ﬁxation resulting in functional
deﬁcit. Descriptive statistics were calculated from each
included study. For continuous data, weighted means and
standard deviations were calculated for all subjects and
outcome parameters. Clinical studies were assessed for
patient-reported outcomes and ROM in comparison of
fascia lata autografts to acellular dermal allografts.
Data Analysis
The Metafor package as part of RStudio software version
1.0.143 (R Foundation for Statistical Computing, Vienna,
Austria) was used for data analysis. Forest plots were
created for VAS, ASES, and ROM (forward ﬂexion [FF]
and external rotation [ER]) (Figs 2, 3, 4, and 5, respectively). The I2 index was used to measure heterogeneity of
included studies.13 Effect sizes were calculated using
random-effects models with the DerSimonian-Laird
estimator, as high heterogeneity precluded use of a
ﬁxed-effects model.14,15
Risk of Bias Assessment
A funnel plot was created to assess publication bias.
Estimated treatment effect for the change in ASES score
was plotted on the x axis, and effect sizes were plotted
on the y axis.16 Study methodological quality was
assessed independently by 2 authors (T.J.S., J.K.) using
the Methodological Index for Non-randomized Studies
(MINORS) score (Table 1; Appendix).

Results
Study Identiﬁcation and Assessment
The following terms were used as keywords and
appeared in the title, abstract, or keyword ﬁelds: (1)
massive rotator cuff tear (n ¼ 463); (2) irreparable
rotator cuff tear (n ¼ 278); (3) superior capsular
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Fig
1. PRISMA
(Preferred
Reporting Items for Systematic
Reviews and Meta-Analyses) ﬂow
chart.

reconstruction (n ¼ 98); and (4) superior capsule
reconstruction (n ¼ 73). The initial keyword search
returned 912 articles for review. After screening for

duplicate citations, 472 articles remained. After
screening for appropriateness based on the title and
abstract, 440 articles were excluded, leaving 32 articles

Fig 2. Forest plot demonstrating
change in visual analogue scale
(VAS) after superior capsular
reconstruction (SCR) with dermal
matrix versus fascia lata grafts.
Abbreviation:
CI
conﬁdence
interval.
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Fig 3. Forest plot demonstrating
change in American Shoulder &
Elbow Surgeons Score (ASES) after superior capsular reconstruction (SCR) with dermal matrix
versus fascia lata grafts. Abbreviation: CI conﬁdence interval.

for full text review. Of those 32, 5 were case reports, 8
were abstracts without available full text, and 3 did not
meet the minimum follow-up. Sixteen studies, all level
of evidence III or IV, reporting clinical outcomes were
included in the ﬁnal review for data extraction and
analysis (Fig 1).12,17-31 All studies lacked randomization
or a control group. The mean MINORS score for all
studies included was 12.4 (Table 1; Appendix). A

Fig 4. Forest plot demonstrating
change in forward ﬂexion (FF)
after superior capsular reconstruction (SCR) with dermal matrix versus fascia lata grafts.
Abbreviation:
CI
conﬁdence
interval.

funnel plot was created to assess publication bias. Estimated treatment effect for the ASES were plotted on
the x axis, and effect sizes were plotted on the y axis.
Point estimates were veriﬁed to be symmetric around
the real estimated treatment effect to demonstrate
limited publication. However, 7 studies were outside
the funnel, which would suggest heterogeneity in
results (Fig 6).16
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Fig 5. Forest plot demonstrating
change in external rotation (ER)
after superior capsular reconstruction (SCR) with dermal matrix versus fascia lata grafts.
Abbreviation:
CI
conﬁdence
interval.

Study and Patient Characteristics
Of the 16 clinical studies, 6 involved fascia lata autografts,12,18,22-24,31 8 involved acellular dermal matrix
allografts,17,19,20,25,27-30 1 involved both fascia lata and
dermal matrix grafts,21 and 1 study involved autologous
hamstring grafts.26 In total, 606 shoulders (598 patients) treated with superior capsular reconstruction
were pooled for evaluation, with a weighted mean
follow-up of 36.9 months (range 12 to 60). Graft types
were fascia lata in 294 patients (49.2%), dermal matrix
in 264 (44.1%), hamstring autograft in 8 (1.3%), and
not disclosed in 32 (5.4%). Graft thickness was a minimum of 5 mm (range 5 to 8) in 294 patients (49.2%), 1
to 3.5 mm in 264 (44.1%), and not disclosed in 40
(6.7%). All of the 5- to 8-mm grafts were fascia lata
grafts, and all of the 1- to 3.5-mm grafts were dermal
matrix grafts. The mean follow-up by graft type was
46.8, 24.2, and 12 months for fascia lata, dermal matrix,
and hamstring grafts, respectively.
Clinical Outcomes
After SCR, the standard mean difference between
postoperative and preoperative state was demonstrated
with respect to the VAS score, ASES score, FF, and ER
(Figs 2, 3, 4, and 5, respectively). VAS scores were reported in 10 studies, and all studies reported
improvements from preoperative (range 4.0 to 6.9 mm)
to
postoperative
(range
0
to
2.5
mm)
values.17,19,20-22,25,27,28,30,31 ASES scores were reported
in 13 studies, and all studies reported improvements
from preoperative (range 20.3 to 54.5) to postoperative
(range 73.7 to 97.0) values.12,17,19-25,27,28,30,31 The
change in FF was reported in 12 studies, with all studies
reporting improvements from preoperative (range
27.0 to 142.7 ) to postoperative (range 134.5 to
167.0 ) values.12,17-19,21-24,27,29,30,31 The change in ER

was reported in 10 studies, with all studies reporting
improvements from preoperative (range 13.2 to 41.0 )
to
postoperative
(range
30.0
to
59.0 )
12,17-19,21-23,27,30,31
values.
Constant scores were reported in 4 studies, all demonstrating improvements
from preoperative (range 17.5 to 56.3) to postoperative
(range 63.7 to 83.5) values.18,21,22,26 Japanese Orthopaedic Association scores were reported in 3 studies, all
demonstrating improvements from preoperative (range
40.6 to 61.2) to postoperative (range 90.6 to 95.2)
values.12,24,31 AHD was reported in 12 studies, and
demonstrated improvements from preoperative (range
3.4 to 7.1 mm ) to postoperative (range 6.0 to 9.7 mm)
values in 11 studies.12,18-22,25-27,30,31 One study
demonstrated a decreased mean AHD postoperatively;
however, this ﬁnding was not statistically signiﬁcant
(P ¼ .6).17
Clinical Outcomes by Graft Type
Clinical studies were differentiated by graft type for
subgroup analysis. One study using both fascia lata and
dermal matrix grafts did not differentiate outcomes for
each subgroup and was therefore excluded.21 For SCR
with dermal allografts, mean VAS improved from 4.0 to
6.3 mm preoperatively to 0 to 1.7 mm postoperatively,
mean ASES 41.8 to 54.0 versus 73.7 to 92.3, mean FF
from 27.0 to 140.0 versus 137.0 to 167.0 , mean ER
from 24.0 to 41.0 versus 35.0 to 59.0 , and mean
AHD from 3.4 to 7.1 mm versus 6.0 to 9.7 mm. For
SCR with fascia lata autografts, mean VAS improved
from 6.0 to 6.9 mm preoperatively to 0.9 to 2.5 mm
postoperatively, mean ASES from 20.3 to 54.4 versus
77.5 to 97.0, mean FF from 36.7 to 142.7
versus 143.8 to 163.6 , mean ER from 13.2 to 32.0
versus 30.0 to 44.0 , and mean AHD from 4.6 to 6.4
mm versus 6.4 to 8.7 mm.
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Table 1. Study Demographic Characteristics and Design
Reference
Mihata et al. 201312

Patients/Shoulders
23/24

Burkhardt and
Hartzler 201917

10/10

Rosales-Varo et al.
201926

Mean
Age (y)
65.1

Mean Follow-Up
(mo)
34.1

69

12.9

8/8

59.6

12

Pennington et al.
201925

86/88

59.4

16 to 28, no
mean reported

Lee and Min 201821

32/36

60.9

24.8

de Campos Azevedo
et al. 201818

22/22

64.8

Denard et al. 201819

59/59

62

17.7

Mihata et al. 201824

88/88

65.3

60

9/9

61.3

32.4

31/31

65.3

15

100/100

66.9

48

64

34

Hirahara et al.
201720
Lim et al. 201922

Mihata et al. 201823

Burkhart et al.
202027

Hirahara et al.
201928

Polacek 201929

41/41

18/18

19/20

63

60

Minimum 24, no
mean reported













































Minimum 12, no
mean reported






Minimum 12, no
mean reported








Study Design/Methodology
Retrospective case series (level IV)
Comparison between retear (þ) and retear (e) groups
No adjustment of confounding variables
No control group
Retrospective case series (level IV)
Power analysis included
No control/comparison groups
No adjustment of confounding variables
Prospective case series (level IV)
No control/comparison groups
No adjustment of confounding variables
Retrospective case series (level IV)
No control/comparison groups
No adjustment of confounding variables
Retrospective-case series (level IV)
Comparison between retear (þ) and retear (e) groups
Adjustment of confounding variables included between
retear groups
Power analysis and pilot study included
No control group
Prospective case series (level IV)
Multiple subgroup comparisons included
Power analysis included
No adjustment of confounding variables
No control group
Prospective case series (level IV)
No control/comparison groups
No adjustment of confounding variables
Retrospective case series (level IV)
No control/comparison groups
No adjustment of confounding variables
Prospective case series (level IV)
Historical control group underwent primary RTC repair
No adjustment of confounding variables
Retrospective case series (level IV)
Comparison between retear (þ) and retear (e) groups
Adjustment of confounding variables included between
retear groups
No control group
Retrospective comparison study (level III)
Comparison between subgroups
No adjustment of confounding variables
No control group
Retrospective case series (level IV)
Subgroup comparisons between 12 mo and 24 mo
follow-up
No adjustment of confounding variables
No control
Retrospective case series (level IV)
Subgroup comparisons between ultrasounds performed
<6 and >12 mo
No adjustment of confounding variables
No control
Prospective case series (level IV)
Subgroup comparisons between 6- and 12-mo
follow-up
No adjustment of confounding variables
No control

MINORS
Score
12 /16

14 /16

12/16

11/16

12/16

14 /16

10/16

10 /16

12/16

13/16

12/16

13/16

13/16

14/16

(continued)
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Table 1. Continued
Reference
Lacheta et al. 202030

Patients/Shoulders
22/22

Mean
Age (y)
56

Mean Follow-Up
(mo)
25





Mihata et al. 201931

30/30

68

Minimum 60, no
mean reported










Study Design/Methodology
Prospective case series (level IV)
Subgroup comparisons between retear (þ) and
retear (e)
Subgroup comparisons between patients with/without
prior RTC repair
Power analysis included
No adjustment of confounding variables
No control
Retrospective case series (level IV)
Subgroup comparisons between retear (þ) and
retear (e)
Subgroup comparisons between 1- and 5-y follow-up
No adjustment of confounding variables
No control

MINORS
Score
14/16

12/16

RTC, rotator cuff.

Complications, Reoperations, and Graft Failures
From all cases of SCR, there were 82 incidences
(13.9%) of retear, loss of ﬁxation, or partially healed
graft at ﬁnal radiologic follow-up (range 0% to 47.6%).
Of the 82 reported failures, 53 reports included the site
of retear or graft failure. Failure occurred on the humeral side in 37 cases (69.8%), intrasubstance in 9
cases (16.9%), and at the glenoid ﬁxation in 7 cases
(13.2%). There were 42 revision surgeries performed
(6.9%, range 0% to 36.1%; 19 revision SCR, 11 RSA,
and 2 balloon spacers). No studies disclosed whether
grafts were reused during revision SCR procedures.
There were 34 complications among all surgeries
(5.6%, range 0% to 15%) (Table 2).

Discussion
This systematic review suggests that SCR for massive
or irreparable rotator cuff tears produces favorable
short-term outcomes, with resultant improvements in
pain, ROM, and other patient-reported outcomes,
irrespective of graft type. In addition, the ﬁndings
demonstrated low rates of SCR graft failure (13.9%),
complications (5.6%), and revision surgeries (6.9%) at
a mean follow-up of >3 years. These outcomes are
especially encouraging given the reported retear rates
after primary repair of massive, irreparable rotator cuff
tears being as high as 94%.6 By comparison, the postoperative complication rate of RSA has been reported to
be as high as 39%, with increasing rates among
younger patient groups.10,32
Recently published systematic reviews have echoed
these ﬁndings, reporting short-term improvements after SCR in both subjective and objective outcomes,
including signiﬁcant improvements in forward elevation and ER.12,33,34 Catapano et al.35 published a
qualitative review of 10 clinical studies in 2019. They
reported improvements in VAS, ASES, FF, and ER, with

a retear rate ranging from 3.4% to 36.1%. However,
that review included 2 studies that were excluded from
our review (1 case report, 1 abstract only).36,37 Galvin
et al.33 published a qualitative review of 5 clinical
studies and 5 biomechanical SCR studies in 2019 and
reported mean improvements in VAS, ROM, and
patient-reported outcomes. Sochacki et al.34 published
a systematic review of SCR clinical studies in 2019 and
showed statistically signiﬁcant improvements in VAS,
ASES, FF, and ER. The average complication, reoperation, and graft failure rates were 3.8%, 11.7%, and
14.2%, respectively. However, that review involved
only 6 clinical studies, one of which was a case
report.19-21,23,25,38
Graft Type and Thickness
The native superior capsule ranges in thickness from
4.4 to 9.1 mm.39 Mihata et al.12 initially described SCR
with a folded, 6- to 8-mm fascia lata autograft. However, concerns of donor site morbidity, shorter operative duration, and ease of graft preparation have led
authors in North America to primarily use thinner, 1- to
3-mm
commercially
available
dermal
allografts.17,19,20,25 Until recently, few studies have
compared the 2 most popular graft types. Galvin
et al.,33 in the qualitative review of 5 clinical and 5
cadaveric studies, suggested improved glenohumeral
stability and decreased subacromial contact pressures
with 8-mm fascia lata grafts compared with 4-mm
acellular dermal allografts. This conclusion was drawn
mainly from the biomechanical cadaveric studies by
Mihata and colleagues,40,41 which demonstrate
improved restoration of glenohumeral mechanics,
decreased thinning, and decreased elongation with a
thicker graft. In their recent systematic review, Makovicka et al.42 described SCR outcomes among various
graft types in 9 clinical and 8 biomechanical studies.
They reported improvements in superior humeral
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Fig 6. A funnel plot was created to assess publication bias.
Estimated treatment effect for the American Shoulder &
Elbow Surgeons Score (ASES) were plotted on the x axis, and
effect sizes were plotted on the y axis. Point estimates were
veriﬁed to be symmetric around the real estimated treatment
effect to demonstrate limited publication bias; however, 7
studies were outside the funnel, which would suggest
heterogeneity in results.

translation, subacromial forces, FF, ER, and patientreported outcomes. However no direct, quantitative
comparison among graft types was performed in that
review.42 Interestingly, our analysis of the available
clinical data comparing fascia lata autografts and dermal
allografts shows similar improvements in VAS, ASES,
FF, and ER between these grafts. Despite differences
found in biomechanical studies, either graft may be an
acceptable option for SCR, with favorable short-term
improvements in pain, ROM, and patient-reported
outcome scores.
Graft Failures
A common debate when discussing graft types in SCR
is the difference in failure rate. Previous studies have
suggested that grafts thicker than 3 mm outperform
thinner grafts, with lower failure rates.19,20 Lee et al.21
reported that grafts >6 mm were more likely to restore
the AHD, demonstrating a statistically signiﬁcant association with graft healing (P < .04). We found the rate
of graft failure to be higher in dermal allografts versus
fascia lata grafts (16.7% versus 9.2%, respectively).
However, there was considerable variation in the 16
clinical studies, with 6 studies reporting failure rates of
30% or greater.17,20-22,29,30 In contrast, Mihata and
colleagues23,24 reported a failure rate of 4 of 24 (16.6%)
in their initial 2013 case series,12 followed by 9 of 188
(4.8%) in subsequent 2018 studies. These ﬁndings
suggest that there may be a signiﬁcant learning curve
associated with SCR.
When SCR graft failure did occur, it happened most
commonly at the site of humeral ﬁxation (69.8%).
Hirahara et al.28 noted that as imaged by ultrasound,

dermal allografts are thickened and highly vascularized
laterally at the humeral ﬁxation site. The authors hypothesized that humeral tension and ﬁxation are crucial
factors in regard to graft healing. Similarly, Catapano
et al.35 reported that 76.7% of graft failures in their review occurred at the humeral ﬁxation site. These ﬁndings may be related to (1) greater tensile forces on the
humeral ﬁxation site during glenohumeral ROM and (2)
acromiohumeral contact abrasion.19 However, it should
be noted that 1 study included in the present review that
reported 13 of 36 failures, all occurring on the humeral
side, performed graft ﬁxation with a single-row technique.21 Conversely, other authors have suggested that
graft failure occurs most commonly at the glenoid ﬁxation or midsubstance.30,43,44,45 Additional clinical studies
with long-term follow-up data are needed to determine
ideal graft tensioning, as well as to assess whether there
are signiﬁcant clinical manifestations of the elongation
and thinning of the dermal allograft as observed in
biomechanical studies. Interestingly, Polacek29 reported
a 15% rate of early graft failure secondary to immunologic rejection of the dermal allograft. All patients had
underlying immunologic disorders and experienced graft
disintegration within several weeks of surgery. The
optimal graft choice for SCR in patients with autoimmune or immunologic conditions remains unclear.
The merits of this systematic review include its large
sample size, with 606 shoulders in 598 patients. In
addition, the 16 included studies involve a variety of
graft types (fascia lata autograft, acellular dermal matrix, and hamstring autograft) and a variety of graft
thicknesses (range 1 to 8 mm). This review also includes a subjective synthesis of outcomes between graft
types, which has not been analyzed in prior reviews on
this topic. In addition, although previous reviews have
demonstrated only moderate levels of heterogeneity,
the mean MINORS score for our pooled clinical studies
demonstrated a high level of methodological quality as
well as a high degree of interobserver reliability.
Limitations
We acknowledge that our analysis has several limitations. First, evaluation of ROM varied between
studies, with some authors using a goniometer and
others reporting values from visual inspection. In
addition, ER was primarily measured with the arm at
the side; however, several studies reporting ER did not
specify arm position.17,22,27 Second, all of the articles
included are level of evidence III and IV, and although
several studies performed subgroup comparisons, no
studies involved a control group or randomization. In
addition, many studies failed to control for confounding
patient and/or procedural variables such as preoperative shoulder function and concomitant surgeries.
Third, 7 of the included studies also demonstrated
heterogeneity among results during the risk of bias
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Table 2. Outcomes after superior capsular reconstruction
Study ID
Mihata et al. 201312

Burkhardt and Hartzler 201917
Rosales-Varo et al. 201926

Pennington et al. 201925
Lee and Min 201821

de Campos Azevedo et al. 201818

Denard et al. 201819

Mihata et al. 201824

Hirahara et al. 201720
Lim et al. 201922
Mihata et al. 201823

Burkhart et al. 202027

Hirahara et al. 201928
Polacek 201929

Lacheta et al. 202030

Mihata et al. 201931

Tendon Involvement
SS (24/24)
IS (23/24)
SSc (9/24)
Tm (1/24)
Unspeciﬁed: 2 tendons fully
torn or tear dimension >5 cm
SS (4/8)
IS (4/8)
NR (4/8)
Massive tear of SS or SS þ IS
No SSc or Tm
SS (36/36)
IS (12/36)
SSc (22/36)
All 3 (20/36)
SS (22/22)
IS (15/22)
SSc (8/22)
All 3 (8/22)
SS (59/59)
IS (56/59)
SSc (33/59)
SS (88/88)
IS (88/88)
SSc (34/88)
Tm (3/88)
All 4 (1/88)
NR
NR
NR

SS (41/41)
IS (41/41)
SSc (30)
NR
SS (20/20)
IS (1/20)
SSc (1/20)
SS (22/22)
IS (22/22)
SSc (2/22)
SS/IS (16/30)
SS/IS/SSc (12/30)
SS/IS/Tm (2/30)

Complications
NR

Graft
Failures (%)
4/24 (16.7)

Revision rate
1 revision SCR

NR

3/10 (30)

0

None

0/8 (0)

None

NR

4/88 (4.5)

1 RSA

NR

13/36 (36.1)

13 revision SCR

Surgical site infection (1)

2/22 (9.1)

0

Deep infection (1)
Failed biceps tenodesis (1)

11/59 (18.6)

2 revision SCR
7 RSA

Suture-anchor pullout (3)
Arthroﬁbrosis (3)
Deep infection (2)
Gluteal muscle discomfort (1)

4/88 (4.5)

0

Infra-/subscapular tear (1)
NR
Suture anchor pullout (4)
Arthroﬁbrosis (2)
Deep infection (2)
Gluteal muscle discomfort (1)
Infra tear (3)
Traumatic rupture of biceps
tenodesis (1)
Fall (2)
Fall (1)
Immunologic graft rejection (3)

3/9 (33.3)
9/31 (29.0)
5/100 (5.0)

1 RSA
0
0

4/26 (15.4)

1 revision SCR
1 RSA
1 RSA
1 revision SCR
2 balloon spacer

Recurrent loss of function (1)

1/18 (5.6)
6/20 (30%,
including 3 graft
rejections)
10/21 (47.6)

Suture anchor pullout (1)

3/30 (10)

0

1 revision SCR

IS, infraspinatus; NR, not reported; RSA, reverse shoulder arthroplasty; SCR, superior capsular reconstruction; SS, supraspinatus; SSc, subscapularis; Tm, teres minor.

assessment. Although no level I or II studies currently
exist on the topic, the low level of evidence limits the
ability to pool data and provide a true quantitative
analysis, and therefore also limits the overall strength of
our conclusions. Fourth, the mean follow-up for our
clinical studies is 36.9 months. Although this is a relatively short follow-up period, the longest follow-up of
any study included is 60 months. Finally, a signiﬁcant
portion of the studies in this review were performed by

small groups of researchers. This may introduce bias
and falsely elevate the number of patients included in
this review, as some patients may have been included
in multiple studies.
Conclusion
Irrespective of tissue source, SCR serves as a reasonable joint-preserving option for massive, irreparable
rotator cuff tears with favorable short- to midterm
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improvements in patient-reported outcomes and range
of motion.
18.
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Appendix
Methods and Results for MINORS Criteria Scoring
MethodsdQuality Assessment
The Methodological Index for Non-randomized
Studies (MINORS) checklist was used to assess the
methodologic quality of included studies. The checklist
assigns a score of 0-2 for 8 items applicable to nonrandomized studies, with a maximum score of 16
indicating the highest possible score for an individual
non-randomized study. The items were scored 0 if not
reported; 1 when reported but inadequate; and 2 when

reported and adequate. A minimum of 12 months was
deemed appropriate length of follow-up. After thorough review of MINORS scoring guidelines, 2 authors
independently reviewed and scored each included
study. Any disagreements in scoring were resolved by
consensus discussion with the senior author.
ResultsdStudy Quality
The included studies were composed of 15 case series
and 1 retrospective comparative study. All clinical
studies were non-randomized. The mean MINORS
score was 12.4 of 16.

